Inventive Planning raised its place in Pfizer Inc. (NYSE:PFE – Free Report) by 17.1% through the third quarter, based on its most up-to-date submitting with the SEC. The agency owned 1,820,731 shares of the biopharmaceutical firm’s inventory after buying an extra 266,167 shares through the interval. Inventive Planning’s holdings in Pfizer had been value $52,692,000 as of its most up-to-date submitting with the SEC.
Numerous different institutional traders additionally not too long ago modified their holdings of PFE. Olistico Wealth LLC acquired a brand new place in Pfizer within the second quarter valued at $25,000. MFA Wealth Advisors LLC purchased a brand new place in shares of Pfizer within the 2nd quarter value about $29,000. Quarry LP acquired a brand new place in shares of Pfizer within the 2nd quarter valued at about $31,000. Trivant Customized Portfolio Group LLC boosted its place in shares of Pfizer by 100.0% through the 1st quarter. Trivant Customized Portfolio Group LLC now owns 1,200 shares of the biopharmaceutical firm’s inventory valued at $33,000 after buying an extra 600 shares within the final quarter. Lastly, Monetary Connections Group Inc. acquired a brand new stake in Pfizer through the second quarter value roughly $34,000. 68.36% of the inventory is owned by institutional traders.
Analyst Upgrades and Downgrades
PFE has been the subject of a lot of analysis analyst experiences. Daiwa Capital Markets upgraded Pfizer from a “impartial” ranking to an “outperform” ranking and elevated their value goal for the inventory from $28.00 to $34.00 in a report on Wednesday, August seventh. StockNews.com upgraded shares of Pfizer from a “maintain” ranking to a “purchase” ranking in a report on Wednesday, October ninth. Wells Fargo & Firm upped their value goal on shares of Pfizer from $28.00 to $30.00 and gave the corporate an “equal weight” ranking in a report on Wednesday, July thirty first. Sanford C. Bernstein assumed protection on Pfizer in a analysis observe on Thursday. They issued a “market carry out” ranking and a $32.00 goal value for the corporate. Lastly, Daiwa America raised Pfizer from a “reasonable purchase” ranking to a “strong-buy” ranking in a analysis observe on Wednesday, August seventh. Seven analysts have rated the inventory with a maintain ranking, six have issued a purchase ranking and one has assigned a powerful purchase ranking to the corporate’s inventory. In response to information from MarketBeat.com, Pfizer has a mean ranking of “Reasonable Purchase” and a consensus goal value of $33.91.
Get Our Newest Inventory Evaluation on PFE
Pfizer Inventory Down 0.2 %
Shares of NYSE:PFE opened at $29.22 on Friday. The inventory has a market cap of $165.58 billion, a price-to-earnings ratio of -487.00, a PEG ratio of 1.02 and a beta of 0.67. The enterprise’s 50 day shifting common is $29.07 and its 200 day shifting common is $28.44. Pfizer Inc. has a 12-month low of $25.20 and a 12-month excessive of $31.54. The corporate has a fast ratio of 0.60, a present ratio of 0.86 and a debt-to-equity ratio of 0.65.
Pfizer (NYSE:PFE – Get Free Report) final posted its earnings outcomes on Tuesday, July thirtieth. The biopharmaceutical firm reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.14. Pfizer had a damaging internet margin of 4.66% and a constructive return on fairness of 8.42%. The agency had income of $13.28 billion through the quarter, in comparison with analyst estimates of $12.96 billion. Throughout the identical quarter within the prior yr, the enterprise posted $0.67 EPS. The enterprise’s income was up 2.1% in comparison with the identical quarter final yr. On common, sell-side analysts forecast that Pfizer Inc. will publish 2.66 earnings per share for the present fiscal yr.
Pfizer Dividend Announcement
The corporate additionally not too long ago introduced a quarterly dividend, which will likely be paid on Monday, December 2nd. Shareholders of file on Friday, November eighth will likely be given a dividend of $0.42 per share. The ex-dividend date is Friday, November eighth. This represents a $1.68 annualized dividend and a dividend yield of 5.75%. Pfizer’s dividend payout ratio is at present -2,800.00%.
About Pfizer
Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical merchandise in the US, Europe, and internationally. The corporate presents medicines and vaccines in numerous therapeutic areas, together with cardiovascular metabolic, migraine, and ladies’s well being below the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin household manufacturers; infectious ailments with unmet medical wants below the Prevnar household, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba manufacturers; and COVID-19 prevention and therapy, and potential future mRNA and antiviral merchandise below the Comirnaty and Paxlovid manufacturers.
Featured Articles
Wish to see what different hedge funds are holding PFE? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Pfizer Inc. (NYSE:PFE – Free Report).
Obtain Information & Rankings for Pfizer Each day – Enter your e mail deal with beneath to obtain a concise day by day abstract of the newest information and analysts’ rankings for Pfizer and associated firms with MarketBeat.com’s FREE day by day e mail e-newsletter.
